About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Blood Advances
›
Top Articles
Blood Advances
Hematology
7.8
(top 1%)
Impact Factor
8.6
(top 1%)
extended IF
71
(top 6%)
H-Index
7K
authors
2.6K
papers
37.2K
citations
2.6K
citing journals
27.4K
citing authors
Most Cited Articles of Blood Advances
Title
Year
Citations
American Society of Hematology 2019 guidelines for immune thrombocytopenia
2019
299
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
2018
289
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
2019
267
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018
263
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
2018
199
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
2018
188
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
2020
187
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
2020
182
Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
2017
164
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
2016
163
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
2021
161
American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism
2018
160
American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism
2018
150
Epidemiology of AL amyloidosis: a real-world study using US claims data
2018
142
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015
2017
133
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
2019
130
Targeted deep sequencing in primary myelofibrosis
2016
120
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity
2018
115
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
2017
114
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
2017
105
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma
2017
103
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
2019
101
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
2020
98
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
2021
96
A neutrophil activation signature predicts critical illness and mortality in COVID-19
2021
93
previous
2018
2019
2020
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.